Having spent nearly a decade at NASH-focused NGM Bio, Aetna Wun Trombley knew it would take some really compelling science to lure her away: “I was at NGM for nine years and I still love that company, ...
On the southwest coast of Turkey, near Greek islands in the southern Aegean Sea, shielded from the Anatolian Plateau by rugged, craggy mountains, lie the ruins of the ancient city of Patara, one of ...
Eli Lilly is signing another protein degradation partner, signaling a growing commitment to the space, which seeks to tackle “undruggable” targets. The Big Pharma is handing over $35 million and ...
Venrock Healthcare Capital Partners led the round, with participation from new investors Janus Henderson Investors, Marshall Wace and Franklin Templeton, and continued support from existing investors ...
SOUTH SAN FRANCISCO, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Lycia Therapeutics, Inc., a leader in extracellular protein degradation, today announced the completion of an oversubscribed $70 million ...
The emerging class of therapies that treat disease by using the cellular process of protein degradation focused first on cancer. But this approach also has potential applications in immunology, and ...
SAN FRANCISCO & SAN DIEGO--(BUSINESS WIRE)--Biotechnology company Lycia Therapeutics, Inc. today exited stealth mode with a $50 million commitment from founding investor Versant Ventures. Proceeds are ...
(RTTNews) - Eli Lilly and Company (LLY) has entered into a research collaboration and licensing agreement with Lycia Therapeutics to address key unmet medical needs in Lilly's therapeutic areas of ...
For over two decades, Arizona's Lycia have been pioneers of “darkwave,” a reverb-drenched, gothic take on dreampop. Quiet Moments, their first release for Handmade Birds, is a somber, but beautiful ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results